Fenbendazole is a broad-spectrum benzimidazole medication that is currently used as an anthelmintic for many parasitic infections in various animal species, including hookworms, pinworms, giardia, and strongyles. It is also undergoing growing exploration for its potential anti-cancer effects. This article delves into the basics of fenbendazole, its uses and dosages in animals, and how it may be applied to humans in the future as an alternative treatment for cancer.
In a series of experiments, EMT6 tumors were grown in BALB/c mice to an average volume of 100 mm3. Mice were then randomized into groups that received three daily i.p. injections of fenbendazole, 10 Gy of x-rays alone, or fenbendazole plus irradiation. Tumor growth after each of these treatments was measured, and the results compared. The data show that fenbendazole, either given alone or combined with irradiation, did not significantly alter tumor growth in unirradiated or irradiated mice (Figure 3).
The reason for this is likely because fenbendazole has very limited absorption in the body when administered at the recommended doses. However, fenbendazole has shown as a slightly to moderately active anticancer agent in cell culture tests, and it has been demonstrated to inhibit glucose uptake in cancer cells.
More recently, a man suffering from stage 4 small cell lung cancer has been documented as being cancer-free after taking fenbendazole aka panacur along with other supplements. While this evidence is not conclusive, it’s certainly encouraging and warrants further exploration. fenbendazole 222mg capsules for humans